Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07823777

Appendectomy as an Adjunct Procedure in Endometriosis Surgery

This study addresses a common but unresolved clinical decision in endometriosis surgery: whether to perform an adjunct appendectomy. Currently, this decision is often based on individual surgeon judgement or institutional practice rather than robust evidence.

This randomized controlled study aims to determine if removing a normal appearing appendix at the time of endometriosis surgery impacts post-operative recurrence of pelvic pain and endometriotic lesions at 12 months. Secondary outcomes include pathology of the appendix and complication rate of the procedure.

Participants will be randomized to appendectomy or no appendectomy at the time of their planned endometriosis surgery. The study also includes an observational cohort that participants may opt to join if they do not wish to be randomized.

Data are expected to guide surgical decision-making and contribute to the development of standardized surgical guidelines.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Endometriosis is a chronic inflammatory disease characterized by the growth of endometrial-like tissue outside the uterine cavity, affecting approximately 1 in 10 women and those assigned female at birth during reproductive years. Surgical excision is a cornerstone of endometriosis disease management, particularly in patients with refractory pain, advanced disease, infertility, bowel or urinary tract involvement, or diagnostic uncertainty. However, outcomes are highly variable due to significant variability in surgical approach, underscoring the need for high quality, prospective evidence to optimize surgical intervention.

Appendiceal involvement presents such an opportunity for optimization, which is estimated to impact anywhere from 10-50% of patients in this population. Currently, only appendices that are visually abnormal at the time of surgery are removed. Existing literature, limited to retrospective data, suggests that the addition of appendectomy at the time of endometriosis surgery decreases the risk of postoperative pain and disease recurrence in patients who have received surgical management, regardless of the visual appearance of the appendix.

Notably, visual assessment of the appendix and confirmation of histopathologic appendiceal involvement are not found to be well-correlated.

At this time, there is a lack of quality prospective data to support implementation of adjunct appendectomy into surgical practice. This study aims to bridge this gap by providing the evidence needed to standardize surgical decision-making.

This randomized controlled study will enroll eligible participants between the ages of 18-50 (pre-menopausal), who will undergo laparoscopic or robotic-assisted excision of endometriosis performed by the Minimally Invasive Surgery (MIS) team at Mount Sinai Hospital in Toronto, ON. If the appendix appears normal intraoperatively, the surgeon will proceed with randomized allocation to either appendectomy or no appendectomy. Participants will remain blinded through follow-up, including validated ENDOPAIN-4D questionnaires administered at 6 and 12 months post-operatively and an endometriosis mapping ultrasound at 12 months post-op.

Additional outcomes will assess whether the risk of intra- and post-surgical complications increase with the addition of an appendectomy compared to laparoscopy alone. Data will also be used to evaluate the prevalence of various appendiceal pathologies, including endometriosis- and non-endometriosis-related.

If a participant is unwilling to be randomized but still wishes to participate, they will be invited to join the observational cohort. Participants in this arm will be given the option of whether or not the appendix should be removed during surgery, should it appear normal, aligning with current standard of care. Participants in this arm will undergo all follow-up milestones in an unblinded manner.

The results of this study will be submitted for publication and for presentation at relevant conferences.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-50 years
  • Endometriosis diagnosis based on imaging or prior surgical findings
  • Baseline pain above 3 on the Numerical Rating Scale (NRS)
  • Undergoing surgical excision of endometriosis only, with at least one remaining ovary

Exclusion criteria

  • Abnormal appearing appendix on imaging or intraoperatively
  • No endometriosis seen at the time of surgery
  • Previous appendectomy
  • Menopausal

Treatment and study plan

Appendectomy

Procedure

Removal of the appendix at the time of endometriosis surgery

Standard of care (SoC)

Procedure

If the appendix appears normal during surgery it will not be removed

Primary outcomes

  1. Change in pelvic pain severity

    Time frame: 1 year

    Change from baseline to 1 year in post-operative pain severity as measured by the ENDOPAIN-4D questionnaire (lower score = less pain)

  2. Rate of endometriosis lesion recurrence

    Time frame: 1 year

    Rates of recurrence of endometriosis lesions based on 12-month endometriosis mapping ultrasound

Secondary outcomes

  1. Change in pelvic pain severity

    Time frame: 6 months

    Change from baseline to 6 months in post-operative pain severity as measured by the ENDOPAIN-4D questionnaire (lower score = less pain)

  2. Change in pelvic pain severity

    Time frame: 6 months

    Change from baseline to 6 months in post-operative pain severity as measured by the Numerical Rating Scale (NRS; lower score = less pain)

  3. Change in pelvic pain severity

    Time frame: 1 year

    Change from baseline to 1 year in post-operative pain severity as measured by the Numerical Rating Scale (NRS; lower score = less pain)

  4. Postoperative complications

    Time frame: 30 days

    Postoperative analgesia use, sleep disturbances, and lifestyle impact at 30 days, reported by participant

  5. Rate of positive appendiceal pathology

    Time frame: 30 days

    Pathology findings from appendix analysis

  6. Types of appendiceal pathology

    Time frame: 30 days

    Types of endometriosis and non-endometriosis appendiceal pathology identified via histopathological analysis of removed appendices

  7. Operative time

    Time frame: During surgery

    Duration of surgery

  8. Postoperative analgesia use

    Time frame: 1 year

    Frequency of analgesic use post-surgery to manage pain

  9. Percentage of eligible participants willing to be randomized

    Time frame: 1 year

    Of those who met study criteria, what percentage were willing to be randomized

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Mount Sinai Hospital, Canada

Other

Registry information

Official study title

Appendectomy as an Adjunct Procedure in Endometriosis Surgery (AppEND)

Acronym: AppEND

Important dates

Study start
2027
Primary completion
2028
Study completion
2029
First posted
Sep 16, 2026
Registry last updated
Sep 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.